Cargando…
Effects of gene therapy on cardiovascular symptoms of lysosomal storage diseases
Lysosomal storage diseases (LSDs) are inherited conditions caused by impaired lysosomal function and consequent substrate storage, leading to a range of clinical manifestations, including cardiovascular disease. This may lead to significant symptoms and even cardiac failure, which is an important ca...
Autores principales: | Poletto, Edina, Pasqualim, Gabriela, Giugliani, Roberto, Matte, Ursula, Baldo, Guilherme |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Sociedade Brasileira de Genética
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6687348/ https://www.ncbi.nlm.nih.gov/pubmed/31132295 http://dx.doi.org/10.1590/1678-4685-GMB-2018-0100 |
Ejemplares similares
-
Effects of Enzyme Replacement Therapy Started Late in a Murine Model of Mucopolysaccharidosis Type I
por: Pasqualim, Gabriela, et al.
Publicado: (2015) -
Comment on “report of 5 novel mutations of the α-L-iduronidase gene and comparison of Korean mutations in relation with those of Japan or China in patients with mucopolysaccharidosis I”
por: Poletto, Edina, et al.
Publicado: (2018) -
Sensitivity, advantages, limitations, and clinical utility of
targeted next-generation sequencing panels for the diagnosis of selected
lysosomal storage disorders
por: Málaga, Diana Rojas, et al.
Publicado: (2019) -
Estimated prevalence of mucopolysaccharidoses from population-based exomes and genomes
por: Borges, Pâmella, et al.
Publicado: (2020) -
Which Is the Best In Silico Program for the Missense Variations in IDUA Gene? A Comparison of 33 Programs Plus a Conservation Score and Evaluation of 586 Missense Variants
por: Borges, Pâmella, et al.
Publicado: (2021)